Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2001

View Archived Issues

Antibody-based therapeutics sought under MorphoSys-Biogen collaboration

Focus on antibody-based cancer therapeutics planned at Immunomedics

Novel antibiotic technology licensed by SIGA

Review of Aventis Behring's Rx for inherited emphysema to be fast-tracked by FDA

Arena to acquire Bunsen Rush Laboratories and its Melanophore Technology

Anticholinergic bronchodilator proves safe and effective as COPD maintenance therapy

Case-control study identifies association between phenylpropanolamine and hemorrhagic stroke

Benzydamine-based activators of soluble guanylate cyclase identified for optimization

Now available: CD-ROM of highlights from the XXII Congress of the ESC

Replagal BLA deemed not approvable by FDA; further data requested

Anagrelide designated an orphan drug by European Commission

Clinical trials expected to begin for ILX-651 this quarter

Effective anti-HIV agents with high selectivity related to T-140

J&J companies will collaborate on development of Maxia compounds for type 2 diabetes

Rho kinase antagonism as a therapeutic alternative for erectile dysfunction

United Therapeutics and Orphan Australia form distribution alliance for UT-15

InterMune seeks approval for Actimmune in Canada; initiates separate phase II trial

Skyrin: a mechanistically novel, small-molecule glucagon antagonist

Use of (S)-oxybutynin for asthma claimed by Sepracor in recent patent

Seroquel may be useful for treating weight gain in psychotic patients

Diphenylethylene and styrene derivatives useful for diabetes

Japanese lab discovers analgesic agents derived from coumarin

New prodrugs synthesized by Sumitomo useful for neurodegenerative disorders

Recent patent covers MMP and TACE inhibitors from Fuji Yakuhin

Therapeutically useful metalloproteinase inhibitors designed at Darwin Discovery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...